❌

Normal view

There are new articles available, click to refresh the page.
Yesterday β€” 28 October 2026The Crypto Basic

SK Hynix ADR Surges as Quarterly Revenue Tops KRW 100 Trillion for First Time

By: Zabi
28 October 2026 at 09:44

SK Hynix ADR Surges as Quarterly Revenue Tops KRW 100 Trillion for First Time

SK hynix (NASDAQ: SKHY) shares surged more than 8% to $157.88 in Wednesday's premarket trading after the South Korean chipmaker reported record third-quarter earnings, with quarterly revenue exceeding KRW 100 trillion for the first time in its history. The company reported third-quarter 2026 revenue of KRW 104.62 trillion, up 328% year over year, while operating profit jumped 632% to KRW 83.33 trillion.

Visit Website

CoreWeave Stock Rises as Denmark AI Capacity Goes Live, Seven-Country Network Expansion Planned

By: Zabi
28 October 2026 at 07:59

CoreWeave Stock Rises as Denmark AI Capacity Goes Live, Seven-Country Network Expansion Planned

CoreWeave (NASDAQ: CRWV) shares rose 3.56% to $61.69 in Wednesday's premarket trading after the AI cloud provider announced Tuesday that it had brought most of its planned 22.5 megawatts (MW) of IT capacity online in Denmark and planned to expand its global network into the Middle East and Asia Pacific. Blackwell Systems at Danish Site; Network Points Planned Across Seven Countries CoreWeave's first Danish deployment is located at atNorth's DEN01 data center in Copenhagen.

Visit Website

Robinhood Shares Slide 8% as Record Q3 Revenue Misses Estimates

By: Zabi
28 October 2026 at 07:31

Robinhood Shares Slide 8% as Record Q3 Revenue Misses Estimates

Robinhood Markets (NASDAQ: HOOD) shares fell more than 8% to $86.78 in premarket trading Wednesday after the online brokerage reported record third-quarter revenue that missed Wall Street estimates, amid weaker cryptocurrency trading and higher operating expenses. Revenue rose 12% year over year to a record $1.42 billion for the quarter ended Sept.

Visit Website

Before yesterdayThe Crypto Basic

SoFi Stock Surges Over 10% After Record Q3 Earnings and Raised Guidance

By: Zabi
27 October 2026 at 09:22

SoFi Stock Surges Over 10% After Record Q3 Earnings and Raised Guidance

SoFi Technologies (NASDAQ: SOFI) shares surged more than 10% to $15.96 in premarket trading Tuesday after the digital financial services company reported record third-quarter 2026 results and raised its full-year earnings and revenue forecasts above Wall Street expectations. Adjusted net revenue rose 44% year over year to a record $1.37 billion, exceeding analysts' expectations of roughly $1.25 billion.

Visit Website

DoorDash Stock Edges Up on Reported $17 Billion Instacart Acquisition Talks

By: Zabi
27 October 2026 at 07:52

DoorDash Stock Edges Up on Reported $17 Billion Instacart Acquisition Talks

DoorDash (NASDAQ: DASH) stock rose 0.43% in premarket trading on Tuesday following reports that the company is in advanced talks to acquire grocery-delivery rival Instacart (NASDAQ: CART) in a potential $17 billion transaction. The Wall Street Journal reported Monday, citing people familiar with the matter, that the companies could reach an agreement as soon as this week.

Visit Website

Broadcom Stock Rises as $63 Billion Financing Backs Anthropic AI Expansion

By: Zabi
27 October 2026 at 07:39

Broadcom Stock Rises as $63 Billion Financing Backs Anthropic AI Expansion

Broadcom (NASDAQ: AVGO) shares rose 2.37% to $337 in Tuesday's premarket trading after Citi, Blackstone, Bank of America, and Morgan Stanley announced a $63 billion financing deal to purchase Broadcom's artificial intelligence equipment for Anthropic. The announcement came at 4:15 p.m.

Visit Website

Moderna Stock Falls 8% as Melanoma Vaccine Selloff Reaches 25%

By: Zabi
26 October 2026 at 10:00

Moderna Stock Falls 8% as Melanoma Vaccine Selloff Reaches 25%

Moderna (NASDAQ: MRNA) shares fell 8% to $184.19 in Monday's early trading, extending the stock's decline to about 25% since the October 21 close after the release of detailed Phase 3 results for its experimental melanoma vaccine developed with Merck (NYSE: MRK). The October 26 decline extended a two-session selloff that began when embargoed INTerpath-001 findings leaked online on October 22.

Visit Website

Nebius Stock Falls Amid Neocloud Debt Concerns After $3.5 Billion Citi Facility

By: Zabi
26 October 2026 at 08:03

Nebius Stock Falls Amid Neocloud Debt Concerns After $3.5 Billion Citi Facility

Nebius Group (NASDAQ: NBIS) shares fell about 4% to $152.74 in premarket trading Monday, continuing an October selloff that began before the AI cloud provider disclosed a $3.5 billion senior secured financing facility from Citi last week. The facility, announced October 22, will help finance Nebius's global data center expansion, GPU purchases and general corporate needs.

Visit Website

American Express Stock Falls as CEO Announces Plan to Cut 5% of Workforce

By: Zabi
23 October 2026 at 10:38

American Express Stock Falls as CEO Announces Plan to Cut 5% of Workforce

American Express (NYSE: AXP) shares fell 3% to $315.38 in early trading Friday after the payments giant announced plans to cut about 5% of its global workforce, even as its third-quarter adjusted earnings surpassed Wall Street expectations. Chief Executive Officer Stephen Squeri disclosed the planned reductions during the company's earnings conference call.

Visit Website

Bloom Energy Stock Falls Despite Q3 Earnings Beat as Operating Cash Flow Turns Negative

By: Zabi
23 October 2026 at 09:24

Bloom Energy Stock Falls Despite Q3 Earnings Beat as Operating Cash Flow Turns Negative

Bloom Energy (NYSE: BE) shares traded near $209 in premarket trading Friday, extending the previous session's losses despite the fuel-cell manufacturer's stronger-than-expected third-quarter earnings and increased full-year guidance. The quarter also recorded a $27.1 million operating cash outflow.

Visit Website

Moderna Stock Tumbles Despite Positive Melanoma Vaccine Trial Results

By: Zabi
23 October 2026 at 07:28

Moderna Stock Tumbles Despite Positive Melanoma Vaccine Trial Results

Moderna (NASDAQ: MRNA) shares plunged more than 17% to $202.63 in Thursday's regular trading session after detailed Phase 3 results for its personalized melanoma vaccine, developed with Merck (NYSE: MRK), emerged earlier than planned despite the treatment meeting key clinical goals. The experimental vaccine, intismeran autogene, combined with Merck's immunotherapy Keytruda reduced the risk of cancer recurrence or death by 42% and the risk of distant metastasis (cancer spreading to other parts of the body) or death by 38% compared with Keytruda alone.

Visit Website

SpaceX Stock Jumps 10% on First Post-IPO Profit, Tesla Merger Explored

By: Zabi
21 October 2026 at 07:29

SpaceX Stock Jumps 10% on First Post-IPO Profit, Tesla Merger Explored

Space Exploration Technologies (NASDAQ: SPCX) shares surged 9.66% to $162.06 in pre-market trading Wednesday after the company reported its first quarterly profit since its June public listing and disclosed that independent committees at SpaceX and Tesla are evaluating a possible merger. SpaceX reported third-quarter net income of $4.4 billion, or $0.35 per diluted share, after posting a $541 million loss in the second quarter and a $1.1 billion loss a year earlier.

Visit Website

Amazon to Invest Over €16 Billion in Germany, Including €4.8 Billion for AWS

By: Zabi
20 October 2026 at 10:06

Amazon to Invest Over €16 Billion in Germany, Including €4.8 Billion for AWS

Amazon.com (NASDAQ: AMZN) announced plans to invest more than €16 billion (approximately $18 billion) in Germany in 2027, including €4.8 billion to expand Amazon Web Services (AWS) cloud infrastructure around Frankfurt. Amazon stock was little changed in early morning trading Tuesday after closing 5% higher at $262.45 on Monday.

Visit Website

CoreWeave Stock Falls as HSBC Flags Debt and AI Demand Risks

By: Zabi
20 October 2026 at 08:18

CoreWeave Stock Falls as HSBC Flags Debt and AI Demand Risks

CoreWeave (NASDAQ: CRWV) shares fell 4.17% to $58.57 in premarket trading on Tuesday, extending their recent decline after HSBC Global Investment Research maintained its 'Reduce' rating and $39 price target. The bank warned that rising borrowing costs and a potential slowdown in demand for AI computing could hurt the company's long-term profitability.

Visit Website

Cerebras Stock Slides as TD Cowen Cuts Target Below IPO Price

By: Zabi
20 October 2026 at 07:34

Cerebras Stock Slides as TD Cowen Cuts Target Below IPO Price

Cerebras Systems (NASDAQ: CBRS) shares fell 3.46% to $116.48 in premarket trading Tuesday, extending losses one day after TD Cowen sharply cut its price target for the artificial intelligence chipmaker while maintaining a Buy rating. TD Cowen lowered its 12-month target to $175 from $275 in a research note issued before Monday's market open.

Visit Website

CoreWeave Stock Jumps 6.5% as Goldman Upgrades Despite Cutting Price Target

By: Zabi
19 October 2026 at 10:25

CoreWeave Stock Jumps 6.5% as Goldman Upgrades Despite Cutting Price Target

CoreWeave (NASDAQ: CRWV) shares rose 6.53% to $65.40 in premarket trading Monday as of 8:46 a.m. ET, after Goldman Sachs upgraded the artificial intelligence infrastructure provider from Neutral to Buy, arguing that investors may be overestimating its future financing costs while undervaluing potential returns from its computing assets.

Visit Website

Nebius Stock Surges as Truist Reaffirms $355 Target After AI Selloff

By: Zabi
19 October 2026 at 08:37

Nebius Stock Surges as Truist Reaffirms $355 Target After AI Selloff

Nebius Group (NASDAQ: NBIS) shares rebounded 7.30% to $177.54 in premarket trading Monday, recovering some of Friday’s sharp losses after Truist Securities reaffirmed its Buy rating and $355 price target. The stock had closed that session at $165.47, down 12.18%, amid broader selling in AI infrastructure companies as investors weighed borrowing costs and the funding required for data center expansion.

Visit Website

Intel Stock Rises 4% as JPMorgan Ends Nearly Four-Year Underweight Stance

By: Zabi
19 October 2026 at 07:12

Intel Stock Rises 4% as JPMorgan Ends Nearly Four-Year Underweight Stance

Intel Corporation (NASDAQ: INTC) shares climbed 4.16% to $93.59 in pre-market trading Monday after JPMorgan upgraded the chipmaker from Underweight to Neutral, ending a negative rating maintained since November 2022. JPMorgan analyst Harlan Sur issued the upgrade in a research note Sunday evening, saying Intel's approximately 36% decline from its June peak had reduced the downside implied by the firm's unchanged $85 price target.

Visit Website

IREN Stock Falls Nearly 4% as Morningstar Cuts Fair Value Estimate to $37 on Financing Risks

By: Zabi
16 October 2026 at 10:57

IREN Stock Falls Nearly 4% as Morningstar Cuts Fair Value Estimate to $37 on Financing Risks

IREN Limited (NASDAQ: IREN) shares fell nearly 4% to $29.23 in Friday's early morning trading after Morningstar lowered its valuation estimate for the AI cloud provider to $37 from $43, citing concerns over rising borrowing costs and competition for capital. The nearly 14% valuation reduction followed Morningstar's warning that specialized AI cloud providers, known as neoclouds, could face higher financing costs as large technology companies raise capital for their own infrastructure expansion.

Visit Website

❌
❌